Share
Chondrocyte implantation, balloon spacers, and the problem with BMI.
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

29 February 2024 | Volume 1 Issue 21

Check out OE

The Pulse

Presented by OrthoEvidence

Good Morning. Recently in the Journal of Bone and Joint Surgery: Dr’s Aaron Gazendam and Michelle Ghert discuss the new developments in musculoskeletal tumour surgery, including novel treatment approaches for soft-tissue tumours and skeletal metastases, key oncologic and functional outcomes, and more.

In today's edition:

⚖️ BMI – has the gold standard of obesity measurement lost its shine?

🏛️ From the AAOS 2024: evidence on autologous chondrocyte implantation vs. microfracture

Radiofrequency ablation > hyaluronic acid for knee osteoarthritis?


BMI

BMI in surgery: is there a better way?

The rise of digital rehab


A former university athlete limps into your office. They’ve got end-stage knee osteoarthritis and are a textbook candidate for joint replacement. But their BMI is over 40. Do you operate or not operate?


BMI has long been used as a measure of obesity. Its convenient, easy to calculate, and is correlated with body fat mass in the general population. But it’s not perfect – and its role as a risk assessment measure, particularly when used as a cutoff for surgery, has put it under increased scrutiny.


In this OE Insight, we discuss everything BMI. We start by looking at the history of BMI, its rise to becoming the standard measure of obesity in clinical research settings, the advantages and disadvantages of BMI – whether its clinical convenience justifies its widespread use – and finally, alternatives that could help surgeons and clinicians make better decisions for their patients.


Read the full OE Insight here.


AAOS 2024

Chondrocyte implantation vs. microfracture for cartilage defects

AAOS 2024: should we wait before treating frozen shoulder?

Microfracture is the go-to treatment for articular cartilage defects. However, there are concerns with degeneration of the fibrocartilaginous tissue – alternatives are thus of interest. Autologous costal chondrocyte implantation is an emerging alternative that has shown a capacity to generate cartilage tissue – and could be a promising intervention for patients with knee cartilage lesions.


30 patients with chondral defects of the knee were randomized to receive a costal chondrocyte-derived pellet-type autologous chondrocyte implantation (n=20) or a microfracture treatment (n=10). The outcomes of interest included knee scores, function scores, pain scores, cartilage repair scores, and treatment failure, all assessed at 5 years post-treatment.

  • Patients who received chondrocyte implantation reported significantly better Magnetic resonance Observation of Cartilage Repair Tissue (MOCART) scores, Lysholm scores, and Knee Injury and Osteoarthritis Outcomes Scores (KOOS) at 5 years compared to the microfracture group.

  • 1 patient in the microfracture group experienced treatment failure.

Bottom line. At 5 years, patients who received chondrocyte implantation demonstrated significantly better knee health and cartilage tissue repair than patients who received microfracture treatment.


Check out the comprehensive analysis of this AAOS abstract here.


OSTEOARTHRITIS

Treating knee pain with cooled radiofrequency ablation

Minimally invasive medial femoral approach: yes or no?

From NSAIDs, to injections, to physical therapy – there are a wide range of interventions for managing knee osteoarthritis non-operatively. Viscosupplementation with hyaluronic acid has been extensively utilized as an injectable intervention, but has limited support from guideline recommendations. Alternative interventions, such as cooled radiofrequency ablation, are growing in popularity – but how does it compare to hyaluronic acid?


177 patients with symptomatic knee osteoarthritis were randomized to receive either radiofrequency lesioning of the genicular nerves (n=89) or a single intra-articular injection of hyaluronic acid (n=88). Follow-up was conducted at 1-, 3-, and 6-months follow-up.

  • Pain improvement was significantly greater in the radiofrequency ablation group compared to the hyaluronic acid group at 1-, 3- and 6-months post-treatment.

  • Pain, function, and stiffness scores on the WOMAC scale were all in favour of the radiofrequency ablation group at all time-points, with exception of stiffness scores at 1 month.

  • General health improvement and quality of life was significantly better in the radiofrequency ablation group at all time-points.

Bottom line. Cooled radiofrequency ablation provided significantly better pain relief, functional improvement and quality of life compared to hyaluronic acid for patients with knee osteoarthritis pain.


Check out our full ACE Report on this paper.

EDITOR’S PICKS


A Trial of Wound Irrigation in Initial Management of Open Fracture Wounds Published in the New England Journal of Medicine (2015), this study aimed to explore the effect of irrigation solutions (soap, saline) at different pressures on reoperation rates, wound healing, and bone healing in patients with open fractures. (Read)


Subacromial Balloon Spacer for Irreparable Rotator Cuff Tears – Published in the Lancet (2022), this study aimed to investigate the effectiveness of a subacromial balloon spacer after debridement vs. debridement only for patients with irreparable rotator cuff tears. The findings were quite interesting... (Read)


Hurt vs. Harm: Exercise and Arthritis – In this OrthoPod, we sat down with Dr. Seper Ekhtiari, orthopaedic surgeon and Cambridge Travelling Fellow, for a conversation on the dichotomy of hurt and arm when it comes to exercise in patients with arthritis. (Watch)

Did you enjoy this newsletter?

I enjoyed it!

It was nothing special

I'm not a fan...


Thanks for reading!



PS. Enjoying The Pulse? Make sure to move it to your primary inbox so you don't miss it!


Any topics you would like to see covered? 

Send your ideas to info@myorthoevidence.com


This email was brought to you by OrthoEvidence


Email Marketing by ActiveCampaign